E Fund Management Co., Ltd. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$249
-7.4%
8,793
-24.9%
0.02%0.0%
Q1 2023$269
-13.8%
11,701
+5.5%
0.02%
-23.1%
Q4 2022$312
-99.9%
11,096
+18.8%
0.03%
+4.0%
Q3 2022$264,000
-12.9%
9,340
-31.7%
0.02%
-7.4%
Q2 2022$303,000
+16.5%
13,673
+53.2%
0.03%
+200.0%
Q1 2022$260,0008,9230.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,710,061$67,074,0101.80%
Bellevue Group AG 4,013,500$99,334,1251.60%
Eagle Health Investments LP 267,630$6,623,8431.46%
ARMISTICE CAPITAL, LLC 3,324,000$82,269,0001.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$11,236,5000.61%
Frazier Life Sciences Management, L.P. 292,002$7,227,0500.48%
ArrowMark Colorado Holdings LLC 1,573,359$38,940,6350.47%
Deep Track Capital, LP 422,247$10,450,6130.40%
FARALLON CAPITAL MANAGEMENT LLC 2,750,829$68,083,0180.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 24,000$593,5200.20%
View complete list of AGIOS PHARMACEUTICALS INC shareholders